Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-25-012690

Options or other derivatives

  • CEO, CFO acquired 323,400 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Finley John David CEO, CFO 2025-09-04 Grant or award · Phantom Units +323,400 323,400 D
Loading xslF345X05/ownership.xml…